BFD - that's the extent of the negative impact of Manchin's proposed bill. Just as in the past, once again he proves that he has negligible influence - just corrupt senator looking out for his own interests.
Best to contact Congressman Scott Peters (D) in 52nd congressional district (San Diego) where Zogenix HQ are located. Tell him about all the potential lost jobs in his district if Z is taken off the market.
I'm sure she will be receptive to exposing Manchin's true motive to ban Z with a follow-up to an article she wrote last month in the Daily Beast. Here's an excerpt:
Joe Manchin’s daughter Heather was looking for a job. The now-senator and one-time governor of West Virginia was only a state level rep when he ran into Milan Pushkar—the head of Mylan Inc., a Fortune 500 pharmaceuticals company—at a West Virginia University basketball game. Heather was hired for an entry-level position at the company soon after. Records show Mylan benefitted from millions of dollars worth of corporate tax breaks in the state during Manchin’s gubernatorial tenure. And these days, after stints as Mylan’s director of government relations and strategic development, Heather Bresch (née Manchin) is the company’s CEO, one of Fortune’s 50 Most Powerful Women in Business. All this without even an MBA—a 2008 investigation found that Bresch did not actually earn her degree from WVU as claimed. Officials had altered her official records and covered up for it, perhaps motivated by Mylan’s lucrative relationship with the University—co-founder Pushkar (Bresch’s business world fairy godfather) donated over $20 million and had the football field named after him.
People will be shocked how quickly the script numbers will grow over first few months. Everyone taking pain meds in the US is now aware of this option - and it's only human nature to want to gain access to a great product when there is a limited supply or talks of outlawing the product - (ex. the first iphones, Teslas, incandescent light bulbs, gun ammunition, ect.)
Guess how many became law? A grand total of one: "A resolution congratulating the Navy Dental Corps on its 100th anniversary"
Most died in committee - just like this latest one will
Search for Forbes article titled "Deloitte's China Problem Comes To A Head" dated 4/2/12
Eerily similar to his piece this AM. First he lays out the 'legwork' he did to establish himself as a 'legitimate' investigative journalist: "My efforts to contact sales staff at Qihoo were challenging to say the least. It took me several weeks of calling, emailing and leaving messages to reach anyone in an attempt to simply place an ad on the site. I employed an ad agency who works extensively with the other 3 top navigation sites in China to undertake the same task and their result was the same."
Then he proceeds to bash the company - to the point where he insinuates that what they are doing borders on fraudulent activity. When this article came out Qihoo PPS was around $24 - now trading at $114 - that's all you need to know.
From the earnings release - a patented approach to obtaining a better resistance to physical and/or chemical means of manipulation:
Our agreement with Altus which we announced immediately after approval of Zohydro ER allows us to pursue another formulation technology now in a tablet dosage form that may have even better resistance to physical and/or chemical means of manipulation as compared to our first approach with Alkermes. Altus is making excellent progress in formulation development towards our goal of a final formulation which meets the product profile. The Altus technology is also associated with new intellectual property, three relevant patterns we issued just last year with additional product specific patent applications in the queue and therefore this would provide a long extension to the IP runway for Zohydro ER.
"I've been asked by the board to drive growth of the company. The mandate for the new CEO is growth."
"I think Kodak has always had an incredible global platform," Clarke said. "It always had the innovation, the ability to create new products. My background is that you can create growth with great products and innovation.
"I've spent the last 11 years in Silicon Valley. Many of these startups would love to have a brand, a distribution network as strong as Kodak. There's huge opportunity for Kodak with functional printing, a huge opportunity for printing on packaging. We're in very good shape going forward."
"abuse-deterrent properties intended to make the tablets more difficult to manipulate for the purpose of misuse and abuse by various routes of administration (e.g., snorting and intravenous injection)"
more difficult? big deal. These new pills are NOT tamper proof. Plus it will be at least a year until they hit the market.
agree - I didn't see him calling for any other opioids to be pulled off the market. Bottom line - this is all free advertising - brand awareness has increased significantly over the past few weeks with ZGNX spending $0 to market the product to end users.